Clinical Profile, Glycemic Management Practices, and Direct Medical Costs among Hospitalized Diabetic Patients in Ethiopia: A Multicenter Prospective Study

Diabetes is a condition where the body struggles to manage sugar in the blood, a vital fuel that powers every cell. When this system fails, sugar levels can drift too high or crash too low, both of which can cause serious harm. For people living with diabetes, a hospital stay is often a time of heightened risk. The stress of an illness, changes in eating habits, and the use of other medications can throw blood sugar levels into chaos. If these levels are not carefully managed while a patient is under medical care, the risk of new complications rises, and the time spent in the hospital often grows longer. This creates a heavy burden not just on the patient's health, but on the healthcare system itself, as treating these complications requires more resources, more tests, and more time.

In Ethiopia, a country where the number of people with diabetes is rising quickly, doctors and researchers wanted to understand exactly what happens when these patients are admitted to the hospital. They sought to learn how well blood sugar was being controlled, what treatments were being used, what complications arose, and how much all of this cost. To find the answers, a team of researchers from Addis Ababa University and other institutions launched a study across three major hospitals in the capital city. They followed nearly four hundred adult patients over several months, watching closely from the moment they arrived until they were discharged or, in some cases, passed away. The goal was to paint a clear picture of the daily reality for these patients and to identify the specific factors that drove up the cost of their care.

The researchers found that the vast majority of the patients they studied had type 2 diabetes, the form of the disease most common in adults, where the body does not use insulin effectively. Most of these individuals had been living with the condition for years before they were admitted. However, a troubling number arrived at the hospital with blood sugar levels that were still too high, suggesting that their condition was not well-managed in their daily lives. Once inside the hospital, the medical teams worked to stabilize them. The most common approach involved giving patients a steady, long-acting dose of insulin to cover their basic needs, along with extra doses to correct any sudden spikes in sugar. This method was used for nearly half of the patients, while others received different combinations of insulin or continued their previous medications.

Despite these efforts, the hospital stay was not without danger for many. Nearly half of the patients developed at least one new complication during their time in the hospital. The most frequent issue was acute kidney injury, a sudden drop in kidney function that can be triggered by infection, dehydration, or the stress of illness. Other common problems included dangerous drops in blood sugar, known as hypoglycemia, and imbalances in the body's salts and minerals. The study showed that the longer a patient stayed in the hospital, the more likely they were to face these additional health hurdles. In total, about seven and a half percent of the patients did not survive their hospitalization, a rate that reflects the severity of the illnesses that brought them in and the complexity of managing diabetes alongside other serious conditions.

The financial toll of these hospitalizations was substantial. The researchers calculated the direct medical costs, which include the price of medications, laboratory tests, imaging scans, and the daily charge for the hospital bed. The median cost for a single hospital stay was four hundred and seventeen US dollars. While this might seem modest compared to costs in wealthier nations, it represents a significant sum in a country where many families pay for healthcare out of their own pockets. The study revealed that the cost was not random; it was driven by specific, predictable factors. The strongest driver was simply the length of the stay. For every additional day a patient remained in the hospital, the cost increased by a small but steady percentage.

Beyond the length of the stay, the number of medications a patient was already taking before they arrived also pushed the total cost higher. Patients who were managing multiple health conditions with several different drugs tended to incur greater expenses, likely because their care required more complex monitoring and coordination. Perhaps most significantly, the development of multiple complications during the hospital stay was a major cost driver. Patients who developed two or more new health problems, such as both kidney injury and an infection, saw their costs jump by more than twenty percent compared to those who remained stable. Interestingly, the specific type of illness that brought the patient in mattered less than the complications that arose while they were there. Whether a patient arrived with an infection, a heart problem, or a kidney issue, the final bill was most heavily influenced by how their body responded to the stress of hospitalization and whether new problems emerged.

The study also highlighted that the type of diabetes diagnosis or the specific blood sugar level upon arrival did not independently predict the final cost. Instead, the economic burden was tied to the patient's overall clinical journey. Those who stayed longer, those who were already taking many medications, and those who suffered multiple setbacks during their stay were the ones who generated the highest expenses. This suggests that the path to reducing costs lies not just in treating the diabetes itself, but in preventing the cascade of complications that often follow. By keeping patients stable, managing their blood sugar carefully to avoid both high and low levels, and treating other health issues promptly, hospitals might be able to shorten stays and lower the financial strain on families and the healthcare system.

The researchers concluded that the clinical and economic challenges faced by hospitalized patients with diabetes in Ethiopia are significant. The data showed that while the medical teams were using established methods to manage blood sugar, the high rate of complications and the resulting length of hospital stays were driving up costs. The findings point to a need for stronger systems to prevent these complications before they start. By improving how diabetes is managed in the community to prevent hospital admissions, and by refining care within the hospital to keep patients stable and avoid new health crises, the burden of this disease could be lightened. The study provides a clear map of where the costs come from, offering a foundation for hospitals and policymakers to build more efficient and effective care strategies for the growing number of people living with diabetes.